$Abeona Therapeutics (ABEO.US)$ NEWS Abeona Therapeutics Ann...
NEWS
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Abeona Therapeutics Inc. announced the pricing of an underwritten offering of common stock and pre-funded warrants, expected to generate approximately $75 million in gross proceeds. The offering includes both new and existing investors, with the funds intended for the resubmission of its BLA, commercialization of its product candidate pz-cel, and general corporate purposes.
Expected gross proceeds of approximately $75 million from the offering.
Inclusion of both new and existing investors, including prominent healthcare-dedicated investors.
Funds to be used for the resubmission of its BLA and commercialization of product candidate pz-cel.
Inclusion of both new and existing investors, including prominent healthcare-dedicated investors.
Funds to be used for the resubmission of its BLA and commercialization of product candidate pz-cel.
Dilution for existing shareholders due to the issuance of new shares.
Potential negative impact on stock price in the short term due to the offering.
Potential negative impact on stock price in the short term due to the offering.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment